{"id":"https://openalex.org/W3016137098","doi":"https://doi.org/10.1080/03639045.2020.1755305","title":"Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma","display_name":"Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma","publication_year":2020,"publication_date":"2020-04-13","ids":{"openalex":"https://openalex.org/W3016137098","doi":"https://doi.org/10.1080/03639045.2020.1755305","mag":"3016137098","pmid":"https://pubmed.ncbi.nlm.nih.gov/32281424"},"language":"en","primary_location":{"id":"doi:10.1080/03639045.2020.1755305","doi":"https://doi.org/10.1080/03639045.2020.1755305","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03639045.2020.1755305","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056167993","display_name":"Dina Fathalla","orcid":"https://orcid.org/0000-0001-9137-1816","observed_orcids":["https://orcid.org/0000-0001-9137-1816","https://orcid.org/0000-0003-3845-529X"]},"institutions":[{"id":"https://openalex.org/I91041137","display_name":"Assiut University","ror":"https://ror.org/01jaj8n65","country_code":"EG","type":"education","lineage":["https://openalex.org/I91041137"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Dina Fathalla","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt;","institution_ids":["https://openalex.org/I91041137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109321580","display_name":"Ehab A. Fouad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91041137","display_name":"Assiut University","ror":"https://ror.org/01jaj8n65","country_code":"EG","type":"education","lineage":["https://openalex.org/I91041137"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ehab A. Fouad","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt;","institution_ids":["https://openalex.org/I91041137"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089180733","display_name":"Ghareb M. Soliman","orcid":"https://orcid.org/0000-0002-9674-1254","observed_orcids":["https://orcid.org/0000-0002-9674-1254"]},"institutions":[{"id":"https://openalex.org/I72264486","display_name":"University of Tabuk","ror":"https://ror.org/04yej8x59","country_code":"SA","type":"education","lineage":["https://openalex.org/I72264486"]},{"id":"https://openalex.org/I91041137","display_name":"Assiut University","ror":"https://ror.org/01jaj8n65","country_code":"EG","type":"education","lineage":["https://openalex.org/I91041137"]}],"countries":["EG","SA"],"is_corresponding":true,"raw_author_name":"Ghareb M. Soliman","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt;","Department of Pharmaceutics, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0002-9674-1254","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt;","institution_ids":["https://openalex.org/I91041137"]},{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia","institution_ids":["https://openalex.org/I72264486"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5089180733"],"corresponding_institution_ids":["https://openalex.org/I72264486","https://openalex.org/I91041137"],"apc_list":null,"apc_paid":null,"fwci":3.3269,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.9338903,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"46","issue":"5","first_page":"806","last_page":"813"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/latanoprost","display_name":"latanoprost","score":1.0},{"id":"https://openalex.org/keywords/niosomes","display_name":"niosomes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.777999997138977},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.9829999804496765},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pluronic-f127","display_name":"Pluronic F127","score":0.9869999885559082},{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.8709999918937683},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.828000009059906},{"id":"https://openalex.org/keywords/eye-irritation","display_name":"eye irritation","score":0.625}],"concepts":[{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.9681494235992432},{"id":"https://openalex.org/C72918618","wikidata":"https://www.wikidata.org/wiki/Q1993211","display_name":"Niosome","level":4,"score":0.9283697605133057},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.7579663991928101},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.5558569431304932},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5217586159706116},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.48994559049606323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47659868001937866},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.47491511702537537},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.4730108082294464},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4134473204612732},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4133464992046356},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.4049122929573059},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36015385389328003},{"id":"https://openalex.org/C130316041","wikidata":"https://www.wikidata.org/wiki/Q189206","display_name":"Vesicle","level":3,"score":0.07454818487167358},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0737893283367157},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05996739864349365},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077338","descriptor_name":"Latanoprost","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000077338","descriptor_name":"Latanoprost","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000077338","descriptor_name":"Latanoprost","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060433","descriptor_name":"Administration, Ophthalmic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065587","descriptor_name":"Ocular Absorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D065587","descriptor_name":"Ocular Absorption","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/03639045.2020.1755305","doi":"https://doi.org/10.1080/03639045.2020.1755305","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03639045.2020.1755305","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},{"id":"pmid:32281424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32281424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development and industrial pharmacy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W84625781","https://openalex.org/W185553516","https://openalex.org/W1567342738","https://openalex.org/W1975970944","https://openalex.org/W1978401291","https://openalex.org/W1979209041","https://openalex.org/W1981652223","https://openalex.org/W1983422848","https://openalex.org/W1989845428","https://openalex.org/W1991203164","https://openalex.org/W1993909229","https://openalex.org/W2003774675","https://openalex.org/W2009451101","https://openalex.org/W2014325374","https://openalex.org/W2022857426","https://openalex.org/W2025595981","https://openalex.org/W2029735514","https://openalex.org/W2034659893","https://openalex.org/W2041723821","https://openalex.org/W2052129346","https://openalex.org/W2058509094","https://openalex.org/W2060272776","https://openalex.org/W2061007879","https://openalex.org/W2062768670","https://openalex.org/W2066598121","https://openalex.org/W2068471000","https://openalex.org/W2072050781","https://openalex.org/W2074889880","https://openalex.org/W2079407952","https://openalex.org/W2081602177","https://openalex.org/W2086872077","https://openalex.org/W2097872314","https://openalex.org/W2098693588","https://openalex.org/W2099355990","https://openalex.org/W2109709772","https://openalex.org/W2112605601","https://openalex.org/W2115439624","https://openalex.org/W2115960427","https://openalex.org/W2130441153","https://openalex.org/W2161530911","https://openalex.org/W2161994187","https://openalex.org/W2501605053","https://openalex.org/W2541462751","https://openalex.org/W2566969499","https://openalex.org/W2748366986","https://openalex.org/W2792395142"],"related_works":["https://openalex.org/W2182775661","https://openalex.org/W2514271279","https://openalex.org/W2078668562","https://openalex.org/W7216002474","https://openalex.org/W2099355990","https://openalex.org/W7091397459","https://openalex.org/W2081602177","https://openalex.org/W4388411589","https://openalex.org/W7134070259","https://openalex.org/W2090044999"],"abstract_inverted_index":{"Objective:":[0],"Glaucoma":[1],"is":[2,12],"a":[3,39,141,175],"leading":[4,28,120],"cause":[5],"of":[6,14,31,48,143,165,177,186],"irreversible":[7],"blindness":[8],"worldwide.":[9],"Whereas":[10],"latanoprost":[11,115,188],"one":[13],"the":[15,44,54,131,148,156],"most":[16],"effective":[17],"drugs":[18],"in":[19,92,94,199],"glaucoma":[20,200],"treatment,":[21],"its":[22],"eye":[23,189],"drops":[24],"need":[25],"frequent":[26],"application":[27],"to":[29,37,102,121,151],"lack":[30],"patient":[32],"adherence.":[33],"This":[34],"study":[35],"aimed":[36],"develop":[38],"patient-friendly":[40],"niosome-in-gel":[41],"system":[42],"for":[43,60,97],"sustained":[45],"ocular":[46],"delivery":[47],"latanoprost.Methods:":[49],"Niosomes":[50],"were":[51,73,85,111],"prepared":[52],"by":[53],"reverse-phase":[55],"evaporation":[56],"technique":[57],"and":[58,67,78,81,100,116,134,167,170],"optimized":[59],"different":[61,76,117],"formulation":[62],"parameters,":[63],"such":[64],"as":[65],"cholesterol/surfactant":[66],"drug/surfactant":[68,132],"ratios.":[69],"Selected":[70],"niosomal":[71,88,118,192],"formulations":[72],"incorporated":[74],"into":[75],"gels":[77],"their":[79],"viscosity":[80],"drug":[82,122,153],"release":[83,154],"kinetics":[84],"evaluated.":[86],"Optimal":[87],"gel":[89,162,195],"was":[90,138,163,181],"evaluated":[91],"vivo":[93],"rabbits\u2019":[95,159],"eyes":[96],"irritation":[98],"potential":[99],"ability":[101,150],"reduce":[103],"intraocular":[104,172],"pressure.Results:":[105],"FT-IR":[106],"studies":[107],"showed":[108],"that":[109,185],"there":[110],"nonspecific":[112],"interactions":[113],"between":[114],"components":[119],"encapsulation":[123,127,135],"efficiency":[124,128,136],"\u226588%.":[125],"Latanoprost":[126,191],"increased":[129],"with":[130],"ratio":[133,142],"\u223c98%":[137],"obtained":[139],"at":[140],"50%.":[144],"Pluronic\u00ae":[145,193],"F127":[146,194],"had":[147],"best":[149],"sustain":[152],"from":[155],"niosomes.":[157],"In":[158],"eyes,":[160],"this":[161],"free":[164],"toxic":[166],"irritant":[168],"effects":[169],"reduced":[171],"pressure":[173],"over":[174],"period":[176],"three":[178],"days,":[179],"which":[180],"significantly":[182],"longer":[183],"than":[184],"commercial":[187],"drops.Conclusion:":[190],"may":[196],"find":[197],"applications":[198],"management.":[201]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-04-17T00:00:00"}